RYDAPT 25 mg, soft capsule 56 capsules
Active ingredients: Midostaurin
Commercialized according to BDPMDispensing in France: Prescription only
Soft capsule56 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RYDAPT 25 mg, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- Conditionnements multiples de 56 (2 boîtes de 28) capsules sous plaquettes polyamide aluminium PVC-Aluminium
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Jul 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67868413CIP73012982CIP133400930129821Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIDOSTAURINEcapsule | 25 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.